Delivery Order SPE2DB24D1107-SPE2DB25FZGG2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,187.70 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen (3 ml), a diabetes medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and an ultimate completion date of August 25, 2025. The contract was executed on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide the Victoza 2-Pak 18 mg/3 ml pen medication. The $1,771.72 award has a performance period through January 13, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,182.36 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 2-pak 18 mg/3 mL pens. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The $1,491.76 order is part of Amerisourcebergen's existing indefinite delivery contract to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp, as the prime contractor, has a history of delivering a range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 3-Pak 18 mg/3 ml pen 3 ml. The contract has a firm fixed price of $26,498.98 and a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 6mg/ml 3ml pens. The $4,237.74 contract has an ultimate completion date of August 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $7,528.10 and a completion date of February 20, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up...
- This federal contract award, SPE2DX15D3006|SPE2DX24F03DZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,009.89 firm fixed-price delivery order is for the supply of Victoza 3-Pak 18 mg/3 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of May 14, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGG2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a ceiling value of $7,126.08. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract was completed on August 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including products for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Victoza is a diabetes management medication, consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices delivered through its federal contracts with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 8/18/25 |